US 11401306
HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof
granted A61KA61K2039/55555A61K2039/585
Quick answer
US patent 11401306 (HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof) held by PDS Biotechnology Corporation expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PDS Biotechnology Corporation
- Grant date
- Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/55555, A61K2039/585, A61K39/12, A61K9/0019